4. Carly Walter

Name: Carly Walter

Company: MAGI

Position: CEO

Website:  https://heymagi.com
 
 

 
 

About Carly Walter

 

I am Carly Walter, founder of MAGI, an AI driven digital health platform supporting neurodivergent females from puberty and beyond. My journey into health innovation began long before the company was formed. For over two decades I experienced misdiagnosis, burnout and repeated breakdowns while being told I was anxious, hormonal or simply not coping. I later received neurodivergent diagnoses in adulthood. That lived experience, combined with a degree in social psychology and years working directly with women in therapeutic settings, became the foundation for building something different.

I formally began developing MAGI after conducting national research with over 500 women and girls. The findings were clear. Neurodivergent females struggle to access timely, preventative support. Care pathways are fragmented, diagnosis is often delayed, and many fall between services until they reach crisis point. Existing digital tools are often productivity focused or symptom driven and do not account for hormonal shifts, sensory overwhelm or fluctuating cognitive capacity.

Building in HealthTech as a female founder in the North of England has come with challenges. I have faced funding barriers, gender bias in both technology and womens health, and the complexity of translating lived experience into scalable digital infrastructure. As a non technical founder leading an AI enabled platform, I have built knowledge across NHS commissioning, compliance standards, ethical design and early stage product development while also managing complex health conditions including PMDD, fibromyalgia and PCOS.

MAGI has now reached MVP stage with pilot routes linked to NHS and commercial settings. The platform is designed as an early intervention infrastructure model, co designed with neurodivergent women and girls and informed by DBT frameworks and adaptive AI logic. It is non clinical and non diagnostic, reducing bias by avoiding traditional medical datasets and embedding lived experience led design with continuous user feedback.

The impact is already growing. MAGI has engaged over 500 research participants nationally, secured NHS support to plan pilot activity, and been selected for international HealthTech trade activity focused on AI collaboration and global partnerships.

My mission is to reduce health inequality and close the support gap experienced by neurodivergent females from puberty through perimenopause and beyond. MAGI is designed to shift the system from crisis response to early intervention, giving users regulation tools, personalised insight and structured support before escalation occurs.
 
50WomenInTech

Check out what TechRound can do for your business: SEOPRHR SoftwarePayroll SoftwareITVoIP.